NCT05094791

Brief Summary

Intertrochanteric fractures are commonly stabilized using an intramedullary nail with a lag screw that enters the lateral cortex of the femur. This lag screw commonly protrudes during the healing process and may cause implant related pain. This study will help determine if implant related pain is different depending to the lag screw design.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

October 4, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

October 26, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 23, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 23, 2024

Completed
Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

2.4 years

First QC Date

October 4, 2021

Last Update Submit

July 26, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Pain at lag screw

    Pain will be accessed at the location of the lag screw, pain will be measured by using a Numeric rating scale (0-100)

    6 weeks

  • Pain at lag screw

    Pain will be accessed at the location of the lag screw, pain will be measured by using a Numeric rating scale (0-100)

    12 weeks

  • Pain at lag screw

    Pain will be accessed at the location of the lag screw, pain will be measured by using a Numeric rating scale (0-100)

    21 weeks

  • Pain at lag screw

    Pain will be accessed at the location of the lag screw, pain will be measured by using a Numeric rating scale (0-100)

    52 weeks

Secondary Outcomes (3)

  • Radiographic lateralization of lag screw

    52 weeks

  • Incidence of lag screw injections

    52 weeks

  • Reoperation rate

    52 weeks

Study Arms (3)

Telescoping Lag Screw

Intertrochanteric fractures treated with Arthrex Hip Nail with Telescoping Screw

Device: Telescoping Lag Screw

Standard lag Screw

Intertrochanteric fractures treated with Zimmer Natural Nail Cephalomedullary Nail

Device: Standard lag Screw

Standard lag screw with addition of worm screw

Intertrochanteric fractures treated with Smith and Nephew TRIGEN INTERTAN

Device: Standard lag screw with addition of worm screw

Interventions

Intertrochanteric fracture fixation using Arthrex Hip Nail with Telescoping Lag Screw

Also known as: Arthrex Hip Nail
Telescoping Lag Screw

Intertrochanteric fracture fixation using Zimmer Natural Nail Cephalomedullary Nail using standard lag screw

Also known as: Zimmer Natural Nail
Standard lag Screw

Intertrochanteric fracture fixation using Smith and Nephew TRIGEN INTERTAN with addition of worm screw

Also known as: Smith and Nephew TRIGEN INTERTAN
Standard lag screw with addition of worm screw

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients sustaining an intertrochantic hip fracture

You may qualify if:

  • Patients greater than or equal to 22 years of age who undergo treatment of an intertrochanteric hip fracture with an intramedullary nail.
  • Fluoroscopic views of the final fixation construct or a post-operative radiograph taken within 24 hours must be available.

You may not qualify if:

  • Non-ambulatory prior to injury (patient must do more than only transfers)
  • Cognitive deficiencies that prevent the patient from providing their own informed consent
  • Inability to follow-up at the discretion of the investigator (incarceration, moving out of area, no permanent housing)
  • Prior fracture to injured hip
  • Prior surgery to injured hip
  • Basi-cervical fracture pattern (fracture that begins above the lesser trochanter and exits medial to the greater trochanter)
  • Patients not treated within 48 hours of admission
  • Chronic or acute infection at site of surgery
  • Language barrier preventing completion of study forms in English
  • Open fracture
  • Fracture related to neoplasm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Greenville Memorial Hosptial

Greenville, South Carolina, 29605, United States

Location

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • John D Adams, MD

    Prisma Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2021

First Posted

October 26, 2021

Study Start

October 4, 2021

Primary Completion

February 23, 2024

Study Completion

February 23, 2024

Last Updated

July 30, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations